关节内类固醇注射联合肩胛上神经阻滞治疗肩关节粘连性囊炎镇痛效果比较:随机临床试验
主要结局为干预后12周肩痛与功能障碍指数(SPADI)改善,结果显示联合组仅在干预后第2周SPADI优于单用组,但后续无差异,联合阻滞未产生临床意义的额外获益。
要点
- 关节内类固醇注射联合肩胛上神经阻滞仅在干预后第2周SPADI优于单用注射,之后无差异。
- 联合组与单用组均显著改善SPADI、VAS、QuickDASH和Constant-Murley ROM评分。
- 联合阻滞未在主要结局上产生临床意义的额外获益,仅即刻VAS有显著下降。
核心结论
- 关节内类固醇注射与联合肩胛上神经阻滞均能改善镇痛、减少功能障碍并增强活动度,但联合阻滞未产生临床意义的额外获益。
主要发现
- 联合组在干预后第2周SPADI评分显著优于单用组(33.6±8.0 vs 38.3±8.9,p=0.04),但之后无显著差异。
- 单用组和联合组在干预当天及第2、6、12周均显著改善SPADI、VAS和QuickDASH评分,并提高Constant-Murley ROM评分(p<0.05)。
- 两组MQS 3评分显著下降至第6周,但联合阻滞除即刻VAS显著下降外未显示临床显著差异。
- 各组生活质量无显著变化(p>0.05)。
临床怎么用
- 对于肩关节粘连性囊炎,关节内类固醇注射可改善镇痛和功能,联合肩胛上神经阻滞的额外获益有限,仅短期VAS可能下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adhesive capsulitis is a distressing ailment that progressively limits the active and passive mobility of the shoulder joint. Physical therapy (PT) combined with intra-articular steroid (IAS) injection and suprascapular nerve block (SSNB) has shown improved functional outcomes. We aimed to assess whether providing both IAS injection and SSNB improved outcomes compared with IAS injection alone. METHODS: Ninety-six patients with adhesive capsulitis were randomized into three groups consisting of group IAS, group IAS+SSNB and group PT (control). All patients were assessed on day 0, week 2, 6 and 12 postintervention. The primary outcome was an improvement in Shoulder Pain and Disability Index (SPADI) scores at week 12 postintervention. Secondary outcomes were Visual Analog Scale (VAS), Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) scores, Constant-Murley Range of Motion (ROM) scores, Quality of life (QoL) and Medication Quantification Scale (MQS) 3. RESULTS: On combining IAS and SSNB, we found a statistically significant improvement in SPADI scores over IAS only at week 2 postintervention (33.6±8.0 vs 38.3±8.9, p=0.04) but not beyond. A significant reduction in SPADI, VAS and QuickDASH scores, along with an improvement in Constant-Murley ROM scores, was observed on day 0 and at weeks 2, 6 and 12 in both group IAS and group IAS+SSNB (p<0.05). MQS 3 scores significantly decreased up to week 6 in both groups. However, the addition of SSNB to IAS did not demonstrate a clinically significant difference in the study outcomes, except for a notable decrease in VAS in the immediate postintervention period. Additionally, no significant changes in QoL were observed among the groups (p>0.05). CONCLUSION: Both IAS and IAS+SSNB improved analgesia, reduced disability and enhanced ROM. However, adding SSNB to IAS did not yield a clinically meaningful benefit in the study outcomes.Trial registration number TRIAL REGISTRATION NUMBER: CTRI/2022/08/044519.
引用
- Elango Y, S A, Swaminathan S, et al. Comparison of the analgesic efficacy of intra-articular steroid injections and its combination with suprascapular nerve block for adhesive capsulitis of the shoulder joint: a randomized clinical trial. Reg Anesth Pain Med. 2026. PMID: 39709187. doi:10.1136/rapm-2024-105902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。